A system for fecal propulsion includes one or more sensors, a stimulator, one or more pairs of electrodes, a controller and a programming device. The sensors detect at least one marker of colonic activity from the enteric, autonomic and/or somatic nervous system. The stimulator generates energy of a particular waveform, intensity and/or time-course to modulate targeted neural circuitry with stimulation parameters being adaptable and dynamic to accommodate the various types of modulated tissues. The electrodes deliver stimulation to the enteric, autonomic and/or somatic nervous systems to control fecal propulsion. The controller and programing device change the stimulation parameters in real-time based on sensor feedback to acutely drive the circuitry from rest to productive defecation. The stimulation waveforms can be simultaneously or sequentially delivered to condition some tissues, while modulating others. The system is adaptive and can be driven through a data analytic repository and machine learning algorithm.

An electrode arrangement is described that is configured to be coupled to a high voltage source for a dielectric barrier discharge plasma treatment of an irregularly three-dimensionally shaped surface of an electrically conducting body. The three-dimensionally shaped surface is used as a counter electrode. A first planar electrode is coupled to the high voltage source via a first lead, fitted to the object to be treated and brought in contact with a dielectric. A second electrode is contacted with the surface to be treated as reference electrode. The second electrode is provided in an edge portion that is circumferential to the first planar electrode and configured to be coupled to a reference voltage source via a second lead. An isolating cover layer covers the electrode and a third electrode covers the isolating cover layer as a ground electrode.

An electrical interferential technique is used to determine operable treatment parameters which are then used to apply a treatment to a patient. A range of beat frequencies is applied to the patient and an indicator of autonomic nervous system activity is measured. When some degree of autonomic nervous system activity is detected, a subsequent trial is conducted using an overlaying range of frequencies, a narrower range or a single frequency, in an attempt to fine tune the reaction of the autonomic nervous system. The subsequent trial may use a different measure of activity of the autonomic nervous system. A garment having a series of electrode sites thereon may be used for a partially trained person to correctly apply electrodes to the patient's body. The treatments may be conducted while the patient is asleep.

A system includes ultrasound transducers configured to generate and direct ultrasound beams at a region within a portion of a subject's brain, sensors configured to measure a response from the portion of the subject's brain in response to one or more ultrasound beams, and an electronic controller in communication with the ultrasound transducers configured to generate, based on a measured response from the portion of the subject's brain in response to two or more ultrasound beams generated from two or more different angles, a model of the portion of the subject's brain, wherein the model has a higher resolution than a maximum resolution of a single ultrasound beam, and generate, based on the model of the portion of the subject's brain, stimulation parameters for the ultrasound transducers to generate and direct a stimulation ultrasound beam at the region within the portion of the subject's brain.

Wearable devices for providing therapy to a patient may include disposable or reusable treatment pads. The treatment pads may include electrodes and are configured to apply energy to various regions around the head and eyes. The treatment pads may provide therapy when the eyes are open or closed. The wearable device may include a battery and/or control circuitry for issuing therapy pulses through the electrodes.

A patient-worn arrhythmia monitoring and treatment device includes at least two pads configured to affix to skin on a torso of a patient. At least one of a pair of sensing electrodes is disposed on each one of the pads and configured to sense surface ECG activity of the patient. At least one of a pair of therapy electrodes is disposed on each one of the pads and configured to deliver one or more therapeutic pulses to the patient. A controller is in communication with the pairs of sensing and therapy electrodes and is configured to monitor for cardiac arrhythmias based on the sensed surface ECG activity and cause the delivery of the one or more therapeutic pulses. The device includes a removable garment to be worn about the torso to immobilize on the torso the one of the at least two pads to which the controller is coupled.

Described herein are noninvasive electrical stimulation devices, systems and methods for stimulation of the Vagus nerve through its auricular branch to provide beneficial physiological responses in subjects, including alleviation, mitigation or elimination of symptoms of various disorders, including metabolic and inflammatory disorders.

In certain examples, methods and structures are directed to an apparatus having a plurality of stretchable leads, with each of the plurality of stretchable leads including an associated electrode which is to receive electrical signals generated in response to a subject-s heart and to pass the received electrical signals along a respective one of plurality of stretchable leads. The apparatus also includes a patch integrating the stretchable substrate with the plurality of stretchable leads and with the patch having an area for circuitry to reside for collecting the electrical signals passed along each of the plurality of stretchable leads, wherein each of the plurality of stretchable leads is to be on a subject side of the patch. In more particular examples, the circuitry is used to provide a multi-lead ECG based on the electrical signals.

A wearable therapeutic device is provided. The wearable therapeutic device includes a garment, and the garment includes an electrode and a conductive thread. A control unit is coupled to the conductive thread and identifies an electrical connection between a conductive surface of the electrode and the conductive thread, and an alarm module can provide information about the positioning of the electrode in the garment based on the electrical connection.

A system for monitoring vital signs, configured to be used in conjunction with a computerized mobile device, the system including: a cover sensor assembly adapted to be operably engaged with the computerized mobile device, the cover sensor assembly having integrated therein at least one physiological sensor; a physiological data acquisition module configured to generate a physiological parameter measurement descriptive of a physical stimulus received by the at least one physiological sensor; and a validation module configured to control a validity status of the physiological parameter measurement.